HUP0100349A3 - Pharmaceutical compositions containing antihyperlipidemic statin-lp(a) inhibitor - Google Patents
Pharmaceutical compositions containing antihyperlipidemic statin-lp(a) inhibitorInfo
- Publication number
- HUP0100349A3 HUP0100349A3 HU0100349A HUP0100349A HUP0100349A3 HU P0100349 A3 HUP0100349 A3 HU P0100349A3 HU 0100349 A HU0100349 A HU 0100349A HU P0100349 A HUP0100349 A HU P0100349A HU P0100349 A3 HUP0100349 A3 HU P0100349A3
- Authority
- HU
- Hungary
- Prior art keywords
- antihyperlipidemic
- statin
- inhibitor
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 230000001315 anti-hyperlipaemic effect Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6943297P | 1997-12-12 | 1997-12-12 | |
| PCT/US1998/023480 WO1999030706A1 (en) | 1997-12-12 | 1998-11-04 | ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0100349A2 HUP0100349A2 (en) | 2001-07-30 |
| HUP0100349A3 true HUP0100349A3 (en) | 2002-02-28 |
Family
ID=22088939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0100349A HUP0100349A3 (en) | 1997-12-12 | 1998-11-04 | Pharmaceutical compositions containing antihyperlipidemic statin-lp(a) inhibitor |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1037623A1 (en) |
| JP (1) | JP2003524582A (en) |
| KR (1) | KR20010033017A (en) |
| AU (2) | AU1306099A (en) |
| BR (1) | BR9813539A (en) |
| CA (1) | CA2299397A1 (en) |
| HU (1) | HUP0100349A3 (en) |
| IL (1) | IL134364A0 (en) |
| IS (1) | IS5385A (en) |
| NO (1) | NO20002965L (en) |
| NZ (1) | NZ502874A (en) |
| PL (1) | PL343851A1 (en) |
| WO (1) | WO1999030706A1 (en) |
| ZA (1) | ZA9811349B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1629849B2 (en) | 1997-01-07 | 2017-10-04 | Amylin Pharmaceuticals, LLC | Pharmaceutical compositions comprising exendins and agonists thereof |
| EP1076091A1 (en) * | 1999-08-09 | 2001-02-14 | Universite Catholique De Louvain | Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| DK1246638T4 (en) * | 2000-01-10 | 2014-09-22 | Amylin Pharmaceuticals Llc | Use of extendins and agonists thereof in the treatment of hypertriglyceridemia |
| AU2001232245A1 (en) * | 2000-02-10 | 2001-08-20 | Takeda Chemical Industries Ltd. | Tnf- alpha inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2016467A1 (en) * | 1989-06-05 | 1990-12-05 | Martin Eisman | Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor |
| WO1993013801A1 (en) * | 1992-01-17 | 1993-07-22 | The Procter & Gamble Company | Treatment for atherosclerosis |
| AU4275793A (en) * | 1992-02-25 | 1993-09-13 | Warner-Lambert Company | Cytoprotective compositions containing pyruvate and antioxidants |
| US5720963A (en) * | 1994-08-26 | 1998-02-24 | Mary Kay Inc. | Barrier disruption treatments for structurally deteriorated skin |
| US5648387A (en) * | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
| EP0738510A3 (en) * | 1995-04-20 | 2005-12-21 | L'oreal | Use of a HMG-CoA reductase inhibitor as an anti-ageing agent and as an anti-acne agent. Composition comprising at least one HMG-CoA reductase inhibitor and at least one active substance with scaling properties. |
| JP2000508659A (en) * | 1996-04-17 | 2000-07-11 | メルク エンド カンパニー インコーポレーテッド | Combination therapy to reduce cardiovascular disease-related risks |
| NZ503982A (en) * | 1997-12-12 | 2002-03-28 | Warner Lambert Co | Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus |
-
1998
- 1998-11-04 IL IL13436498A patent/IL134364A0/en unknown
- 1998-11-04 HU HU0100349A patent/HUP0100349A3/en unknown
- 1998-11-04 NZ NZ502874A patent/NZ502874A/en unknown
- 1998-11-04 EP EP98956562A patent/EP1037623A1/en not_active Ceased
- 1998-11-04 WO PCT/US1998/023480 patent/WO1999030706A1/en not_active Application Discontinuation
- 1998-11-04 PL PL98343851A patent/PL343851A1/en unknown
- 1998-11-04 AU AU13060/99A patent/AU1306099A/en not_active Abandoned
- 1998-11-04 KR KR1020007006370A patent/KR20010033017A/en not_active Application Discontinuation
- 1998-11-04 JP JP2000538689A patent/JP2003524582A/en active Pending
- 1998-11-04 BR BR9813539-2A patent/BR9813539A/en not_active Application Discontinuation
- 1998-11-04 CA CA002299397A patent/CA2299397A1/en not_active Abandoned
- 1998-12-10 ZA ZA9811349A patent/ZA9811349B/en unknown
-
2000
- 2000-02-25 IS IS5385A patent/IS5385A/en unknown
- 2000-06-09 NO NO20002965A patent/NO20002965L/en not_active Application Discontinuation
-
2003
- 2003-08-29 AU AU2003244047A patent/AU2003244047A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL343851A1 (en) | 2001-09-10 |
| NO20002965D0 (en) | 2000-06-09 |
| AU2003244047A1 (en) | 2003-09-25 |
| NZ502874A (en) | 2004-03-26 |
| CA2299397A1 (en) | 1999-06-24 |
| AU1306099A (en) | 1999-07-05 |
| IL134364A0 (en) | 2001-04-30 |
| HUP0100349A2 (en) | 2001-07-30 |
| EP1037623A1 (en) | 2000-09-27 |
| JP2003524582A (en) | 2003-08-19 |
| IS5385A (en) | 2000-02-25 |
| WO1999030706A1 (en) | 1999-06-24 |
| BR9813539A (en) | 2000-10-10 |
| KR20010033017A (en) | 2001-04-25 |
| ZA9811349B (en) | 1999-06-14 |
| NO20002965L (en) | 2000-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL193245A0 (en) | Pharmaceutical compositions containing an a?? fragment | |
| HUP0002209A3 (en) | 4-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical compositions containing them | |
| PL331531A1 (en) | Pharmaceutical aerosol compositions | |
| HUP0001013A3 (en) | Oil-free pharmaceutical compositions containing cyclosporin a | |
| HUT77377A (en) | Pharmaceutical aerosol compositions | |
| GB9727053D0 (en) | Pharmaceutical compositions | |
| CY2569B1 (en) | Pharmaceutical compositions | |
| HUT74746A (en) | Pharmaceutical compositions containing p antagonist | |
| PL334568A1 (en) | Paroxetin containing compositions | |
| IL112639A0 (en) | A pharmaceutical composition containing pravastin | |
| IL133928A0 (en) | Pharmaceutical composition containing peptichemio | |
| IL131995A0 (en) | Gastric-retained pharmaceutical compositions | |
| GB9723985D0 (en) | Pharmaceutical compositions | |
| ZA9811532B (en) | Pharmaceutical compositions | |
| IL134651A0 (en) | Pharmaceutical compositions containing an anti-androgen | |
| HUP0100349A3 (en) | Pharmaceutical compositions containing antihyperlipidemic statin-lp(a) inhibitor | |
| HU9700632D0 (en) | Pharmaceutical compositions | |
| IL128107A0 (en) | Pharmaceutical compositions containing a pkc inhibitor | |
| GB9823913D0 (en) | Decontamination compositions | |
| GB9921495D0 (en) | Pharmaceutical compositions | |
| HUP0003528A3 (en) | Pharmaceutical compositions containing dihydropolyprenols | |
| GB2285923B (en) | Pharmaceutical compositions containing N-acetal-cysteine | |
| HU9701093D0 (en) | Pharmaceutical composition containing huminic acid | |
| PL330972A1 (en) | Tetrahydrolypstatin containing compositions | |
| HUP0004274A3 (en) | Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof |